Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.6M Sell
79,500
-49,500
-38% -$10.6M 0.8% 50
2026
Q1
$25.8M Buy
129,000
+17,500
+16% +$3.77M 0.86% 47
2025
Q4
$25.5M Buy
+111,500
New +$23.3M 0.82% 48
2023
Q4
Sell
-1,012,145
Closed -$44.8M 84
2023
Q3
$44.8M Sell
1,012,145
-140,706
-12% -$7.18M 1.42% 24
2023
Q2
$56.1M Buy
1,152,851
+170,610
+17% +$8.7M 1.83% 14
2023
Q1
$54.5M Sell
982,241
-638,771
-39% -$30.7M 1.8% 17
2022
Q4
$65.1M Buy
+1,621,012
New +$66.8M 2.18% 11

Other funds holding NTRA

Braidwell's NTRA Position: Q2 2026 in Review

Braidwell reduced its Natera (NTRA) stake by 38% in Q2 2026, selling an estimated $10.6M and leaving 79,500 shares worth $21.6M. The position accounts for 0.8% of the portfolio, ranked #50.

Braidwell first reported a position in NTRA in Q4 2022 and has held it in 7 quarters since. The position peaked at $65.1M in Q4 2022. 846 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • Braidwell held 79,500 shares of Natera worth $21.6M as of Q2 2026.
  • Braidwell sold 49,500 Natera shares in Q2 2026, an estimated $10.6M.
  • Natera made up 0.8% of Braidwell's portfolio in Q2 2026, its #50 holding.
  • Braidwell first reported a position in Natera in Q4 2022 and has held it in 7 quarters since.
  • Braidwell's Natera position peaked at $65.1M in Q4 2022.
  • 846 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.